Chemoinformaics analysis of 11,13alpha-dihydroeuperfolide
| Molecular Weight | 250.338 | nRot | 0 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 17 |
| Exact Molecular Weight | 250.157 | nRing | 3 |
| Solubility: LogS | -4.459 | nHRing | 2 |
| Solubility: LogP | 3.53 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 42.1254 |
| nHD | 0 | BPOL | 26.4106 |
| QED | 0.377 |
| Synth | 4.689 |
| Natural Product Likeliness | 3.517 |
| NR-PPAR-gamma | 0.046 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.021 |
| Pgp-sub | 0.003 |
| HIA | 0.012 |
| CACO-2 | -4.627 |
| MDCK | 0.0000265 |
| BBB | 0.772 |
| PPB | 0.795875 |
| VDSS | 1.362 |
| FU | 0.210319 |
| CYP1A2-inh | 0.209 |
| CYP1A2-sub | 0.369 |
| CYP2c19-inh | 0.189 |
| CYP2c19-sub | 0.695 |
| CYP2c9-inh | 0.051 |
| CYP2c9-sub | 0.09 |
| CYP2d6-inh | 0.058 |
| CYP2d6-sub | 0.263 |
| CYP3a4-inh | 0.615 |
| CYP3a4-sub | 0.275 |
| CL | 6.287 |
| T12 | 0.262 |
| hERG | 0.061 |
| Ames | 0.017 |
| ROA | 0.097 |
| SkinSen | 0.747 |
| Carcinogencity | 0.099 |
| EI | 0.371 |
| Respiratory | 0.949 |
| NR-Aromatase | 0.021 |
| Antiviral | Yes |
| Prediction | 0.915352 |